401(k) · DOL Form 5500 · 2022
Endo Health Solutions Inc. 401(k) Plan
Data updated 2026-08-11
- $434M
- Total assets
- 1,505
- Participants
- 98th
- Percentile by assets
- $288,264
- Avg per participant
Official DOL plan name: Endo Pharmaceuticals Savings and Investment Plan · Sponsored by Endo Health Solutions Inc. · Pennsylvania · Manufacturing
$434M in assets, 1,505 participants
Endo Health Solutions Inc.'s Endo Pharmaceuticals Savings and Investment Plan reported $434M in total assets and 1,505 participants in its 2022 DOL Form 5500 filing, ranking in the 98th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.
- 98th percentile by assets (of 139,126 plans)
- #19,785 in Manufacturing (20,602 peers)
Where Endo Pharmaceuticals Savings and Investment Plan sits by assets
Endo Pharmaceuticals Savings and Investment Plan sits in the top 5% of all filed plans by assets, $434M for 1,505 participants (~$288,264/participant), down 23.3% in 2022.
- $434M
- total plan assets (2022 EOY)
- 1,505
- covered participants
- 98th
- percentile by assets (of 139,126 plans)
- $288,264
- avg assets per participant
The plan reported a net loss of $132M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.
Endo Pharmaceuticals Savings and Investment Plan vs the 2022 asset distribution
By assets, Endo Pharmaceuticals Savings and Investment Plan outranks 98% of the 139,126 plans that filed a Form 5500 for the 2022 plan year, and holds roughly 4.4x the national average plan size of $100M (721 average participants).
Scale-class filing particulars (2022)
| Total Assets (Beginning of Year) | $565M |
|---|---|
| Net Assets (End of Year) | $434M |
| Net Income | -$132M |
| Employer EIN | 522035829 |
| Plan Effective Date | 1997-09-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Endo Health Solutions Inc.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 1,505 | $434M |
| 2023 | 1 | 1,322 | $492M |
Nearby 401(k) Plans in Pennsylvania
Peer 401(k) plans, same state, same plan type, ranked by total assets.
Endo Pharmaceuticals Savings and Investment Plan vs. nearby 401(k) plans in Pennsylvania, assets vs. participants
- Comcast Corporation Retirement - Investment Plan $14.8B · 97,769
- Cigna 401(k) Plan $11.5B · 66,147
- The PNC Financial Services Group, Inc. Incentive Savings Plan $8.1B · 59,451
- The Vanguard Retirement and Savings Plan $8.1B · 17,073
- The Bank of New York Mellon Corporation 401(k) Savings Plan $7.8B · 25,071
Similar-Sized 401(k) Plans Nationally
401(k) plans in other states closest to Endo Pharmaceuticals Savings and Investment Plan by total assets, not by location.
- Paychex Pooled Employer 401(k) Plan (NY) $434M · 299,256
- Albany Medical Center 403 (B) Plan (NY) $433M · 9,167
- Healthfirst Profit Sharing 401(k) Plan (NY) $433M · 4,992
- Integer 401(k) Plan (TX) $435M · 3,641
Frequently Asked Questions
How did Endo Pharmaceuticals Savings and Investment Plan assets move in 2022? ▼
How have Endo Health Solutions Inc. plan assets changed over time? ▼
Where does Endo Pharmaceuticals Savings and Investment Plan rank by assets among Form 5500 filers? ▼
Which 401(k) plans are similar in size to Endo Pharmaceuticals Savings and Investment Plan? ▼
Next read for Endo Pharmaceuticals Savings and Investm…
Scale reading
Ways to act on Endo Pharmaceuticals Savings and Investment Plan's numbers.
- By total assets, Endo Pharmaceuticals Savings and Investment Plan ranks in the top 5% of all filed plans by assets. See the largest plans
- Compare it side-by-side against 3 similar 401(k) plans in Pennsylvania. Compare plans
- Endo Health Solutions Inc.'s sponsor-wide assets have grown 13.4% since 2022 across 2 plan years on file. More Manufacturing plans